Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Malignant Mesothelioma Therapeutic Market Size Growth Rate by Type (2014-2025) 1.4.2 Oral 1.4.3 Parenteral 1.5 Market by Application 1.5.1 Global Malignant Mesothelioma Therapeutic Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Oncology Centers 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Malignant Mesothelioma Therapeutic Market Size 2.2 Malignant Mesothelioma Therapeutic Growth Trends by Regions 2.2.1 Malignant Mesothelioma Therapeutic Market Size by Regions (2014-2025) 2.2.2 Malignant Mesothelioma Therapeutic Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Malignant Mesothelioma Therapeutic Market Size by Manufacturers 3.1.1 Global Malignant Mesothelioma Therapeutic Revenue by Manufacturers (2014-2018) 3.1.2 Global Malignant Mesothelioma Therapeutic Revenue Market Share by Manufacturers (2014-2018) 3.1.3 Global Malignant Mesothelioma Therapeutic Market Concentration Ratio (CR5 and HHI) 3.2 Malignant Mesothelioma Therapeutic Key Players Head office and Area Served 3.3 Key Players Malignant Mesothelioma Therapeutic Product/Solution/Service 3.4 Date of Enter into Malignant Mesothelioma Therapeutic Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) 4.2 Global Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) 5 United States 5.1 United States Malignant Mesothelioma Therapeutic Market Size (2014-2019) 5.2 Malignant Mesothelioma Therapeutic Key Players in United States 5.3 United States Malignant Mesothelioma Therapeutic Market Size by Type 5.4 United States Malignant Mesothelioma Therapeutic Market Size by Application 6 Europe 6.1 Europe Malignant Mesothelioma Therapeutic Market Size (2014-2019) 6.2 Malignant Mesothelioma Therapeutic Key Players in Europe 6.3 Europe Malignant Mesothelioma Therapeutic Market Size by Type 6.4 Europe Malignant Mesothelioma Therapeutic Market Size by Application 7 China 7.1 China Malignant Mesothelioma Therapeutic Market Size (2014-2019) 7.2 Malignant Mesothelioma Therapeutic Key Players in China 7.3 China Malignant Mesothelioma Therapeutic Market Size by Type 7.4 China Malignant Mesothelioma Therapeutic Market Size by Application 8 Japan 8.1 Japan Malignant Mesothelioma Therapeutic Market Size (2014-2019) 8.2 Malignant Mesothelioma Therapeutic Key Players in Japan 8.3 Japan Malignant Mesothelioma Therapeutic Market Size by Type 8.4 Japan Malignant Mesothelioma Therapeutic Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Malignant Mesothelioma Therapeutic Market Size (2014-2019) 9.2 Malignant Mesothelioma Therapeutic Key Players in Southeast Asia 9.3 Southeast Asia Malignant Mesothelioma Therapeutic Market Size by Type 9.4 Southeast Asia Malignant Mesothelioma Therapeutic Market Size by Application 10 India 10.1 India Malignant Mesothelioma Therapeutic Market Size (2014-2019) 10.2 Malignant Mesothelioma Therapeutic Key Players in India 10.3 India Malignant Mesothelioma Therapeutic Market Size by Type 10.4 India Malignant Mesothelioma Therapeutic Market Size by Application 11 Central & South America 11.1 Central & South America Malignant Mesothelioma Therapeutic Market Size (2014-2019) 11.2 Malignant Mesothelioma Therapeutic Key Players in Central & South America 11.3 Central & South America Malignant Mesothelioma Therapeutic Market Size by Type 11.4 Central & South America Malignant Mesothelioma Therapeutic Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 Malignant Mesothelioma Therapeutic Introduction 12.1.4 AstraZeneca Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.1.5 AstraZeneca Recent Development 12.2 Bristol-Myers Squibb 12.2.1 Bristol-Myers Squibb Company Details 12.2.2 Company Description and Business Overview 12.2.3 Malignant Mesothelioma Therapeutic Introduction 12.2.4 Bristol-Myers Squibb Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.2.5 Bristol-Myers Squibb Recent Development 12.3 Roche 12.3.1 Roche Company Details 12.3.2 Company Description and Business Overview 12.3.3 Malignant Mesothelioma Therapeutic Introduction 12.3.4 Roche Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.3.5 Roche Recent Development 12.4 Merck 12.4.1 Merck Company Details 12.4.2 Company Description and Business Overview 12.4.3 Malignant Mesothelioma Therapeutic Introduction 12.4.4 Merck Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.4.5 Merck Recent Development 12.5 Novartis 12.5.1 Novartis Company Details 12.5.2 Company Description and Business Overview 12.5.3 Malignant Mesothelioma Therapeutic Introduction 12.5.4 Novartis Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.5.5 Novartis Recent Development 12.6 Pfizer 12.6.1 Pfizer Company Details 12.6.2 Company Description and Business Overview 12.6.3 Malignant Mesothelioma Therapeutic Introduction 12.6.4 Pfizer Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.6.5 Pfizer Recent Development 12.7 Sanofi 12.7.1 Sanofi Company Details 12.7.2 Company Description and Business Overview 12.7.3 Malignant Mesothelioma Therapeutic Introduction 12.7.4 Sanofi Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.7.5 Sanofi Recent Development 12.8 Eli Lilly 12.8.1 Eli Lilly Company Details 12.8.2 Company Description and Business Overview 12.8.3 Malignant Mesothelioma Therapeutic Introduction 12.8.4 Eli Lilly Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.8.5 Eli Lilly Recent Development 12.9 Teva Pharmaceuticals 12.9.1 Teva Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Malignant Mesothelioma Therapeutic Introduction 12.9.4 Teva Pharmaceuticals Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.9.5 Teva Pharmaceuticals Recent Development 12.10 Boehringer Ingelheim GmbH 12.10.1 Boehringer Ingelheim GmbH Company Details 12.10.2 Company Description and Business Overview 12.10.3 Malignant Mesothelioma Therapeutic Introduction 12.10.4 Boehringer Ingelheim GmbH Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) 12.10.5 Boehringer Ingelheim GmbH Recent Development 12.11 Mylan 12.12 Fresenius Kabi 12.13 Sun Pharmaceuticals 12.14 Corden Pharma 12.15 Concordia International 12.16 Kyowa Hakko Kirin 12.17 Polaris Pharmaceuticals 12.18 MolMed 12.19 Ono Pharmaceutical 12.20 Nichi-Iko Pharmaceutical 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Malignant Mesothelioma Therapeutic Key Market Segments Table Key Players Malignant Mesothelioma Therapeutic Covered Table Global Malignant Mesothelioma Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Malignant Mesothelioma Therapeutic Market Size Market Share by Type 2014-2025 Figure Oral Figures Table Key Players of Oral Figure Parenteral Figures Table Key Players of Parenteral Table Global Malignant Mesothelioma Therapeutic Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Oncology Centers Case Studies Figure Other Case Studies Figure Malignant Mesothelioma Therapeutic Report Years Considered Table Global Malignant Mesothelioma Therapeutic Market Size 2014-2025 (Million US$) Figure Global Malignant Mesothelioma Therapeutic Market Size and Growth Rate 2014-2025 (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Size by Regions 2014-2025 (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Size by Regions 2014-2019 (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Share by Regions 2014-2019 Figure Global Malignant Mesothelioma Therapeutic Market Share by Regions 2014-2019 Figure Global Malignant Mesothelioma Therapeutic Market Share by Regions 2019 Table Market Top Trends Table Global Malignant Mesothelioma Therapeutic Revenue by Manufacturers (2014-2019) (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Share by Manufacturers (2014-2019) Figure Global Malignant Mesothelioma Therapeutic Market Share by Manufacturers in 2018 Table Global Malignant Mesothelioma Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Malignant Mesothelioma Therapeutic Product/Solution/Service Table Date of Enter into Malignant Mesothelioma Therapeutic Market Table Mergers & Acquisitions, Expansion Plans Table Global Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Size Share by Type (2014-2019) Figure Global Malignant Mesothelioma Therapeutic Market Size Market Share by Type (2014-2019) Table Global Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table Global Malignant Mesothelioma Therapeutic Market Size Share by Application (2014-2019) Figure Global Malignant Mesothelioma Therapeutic Market Size Market Share by Application (2014-2019) Figure Global Malignant Mesothelioma Therapeutic Revenue Market Share by Application in 2018 Figure United States Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table United States Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table United States Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table United States Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table United States Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table United States Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table United States Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure Europe Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table Europe Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table Europe Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table Europe Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table Europe Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table Europe Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table Europe Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure China Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table China Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table China Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table China Malignant Mesothelioma Therapeutic Market Size by Type (2014-20189) (Million US$) Table China Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table China Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table China Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure Japan Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table Japan Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table Japan Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table Japan Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table Japan Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table Japan Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table Japan Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure Southeast Asia Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table Southeast Asia Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table Southeast Asia Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure India Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table India Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table India Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table India Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table India Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table India Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table India Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Figure Central & South America Malignant Mesothelioma Therapeutic Market Size 2014-2019 (Million US$) Table Central & South America Key Players Malignant Mesothelioma Therapeutic Revenue (2018-2019) (Million US$) Table Central & South America Key Players Malignant Mesothelioma Therapeutic Market Share (2018-2019) Table Central & South America Malignant Mesothelioma Therapeutic Market Size by Type (2014-2019) (Million US$) Table Central & South America Malignant Mesothelioma Therapeutic Market Share by Type (2014-2019) Table Central & South America Malignant Mesothelioma Therapeutic Market Size by Application (2014-2019) (Million US$) Table Central & South America Malignant Mesothelioma Therapeutic Market Share by Application (2014-2019) Table AstraZeneca Company Details Table AstraZeneca Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019) (Million US$) Figure AstraZeneca Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table AstraZeneca Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Roche Company Details Table Roche Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Roche Recent Development Table Merck Company Details Table Merck Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Merck Recent Development Table Novartis Company Details Table Novartis Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Pfizer Recent Development Table Sanofi Company Details Table Sanofi Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Sanofi Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Eli Lilly Recent Development Table Teva Pharmaceuticals Company Details Table Teva Pharmaceuticals Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Teva Pharmaceuticals Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Teva Pharmaceuticals Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Revenue in Malignant Mesothelioma Therapeutic Business (2014-2019)(Million US$) Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Malignant Mesothelioma Therapeutic Business (2014-2019) Table Boehringer Ingelheim GmbH Recent Development Table Mylan Company Details Table Fresenius Kabi Company Details Table Sun Pharmaceuticals Company Details Table Corden Pharma Company Details Table Concordia International Company Details Table Kyowa Hakko Kirin Company Details Table Polaris Pharmaceuticals Company Details Table MolMed Company Details Table Ono Pharmaceutical Company Details Table Nichi-Iko Pharmaceutical Company Details Table Global Malignant Mesothelioma Therapeutic Market Size by Regions (Million US$) 2019-2025 Figure Global Malignant Mesothelioma Therapeutic Market Size Share by Regions (2019-2025) Figure Global Malignant Mesothelioma Therapeutic Market Size Share by Regions in 2025 Figure United States Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure Europe Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure China Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure Japan Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure India Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Malignant Mesothelioma Therapeutic Market Size Forecast (2019-2025)(Million USD) Table Global Malignant Mesothelioma Therapeutic Market Size by Product (2019-2025) (Million US$) Figure Global Malignant Mesothelioma Therapeutic Market Size by Product (2019-2025) Figure Global Malignant Mesothelioma Therapeutic Market Size by Product in 2025 Table Global Malignant Mesothelioma Therapeutic Market Size by Application (2019-2025) (Million US$) Figure Global Malignant Mesothelioma Therapeutic Market Size by Application (2019-2025) Figure Global Malignant Mesothelioma Therapeutic Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Bristol-Myers Squibb Roche Merck Novartis Pfizer Sanofi Eli Lilly Teva Pharmaceuticals Boehringer Ingelheim GmbH Mylan Fresenius Kabi Sun Pharmaceuticals Corden Pharma Concordia International Kyowa Hakko Kirin Polaris Pharmaceuticals MolMed Ono Pharmaceutical Nichi-Iko Pharmaceutical